cytarabine has been researched along with 1-methyl-4-phenylpyridinium in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dalia, A; Hadjiconstantinou, M; Neff, NH | 1 |
Agid, Y; Michel, PP; Ruberg, M | 1 |
2 other study(ies) available for cytarabine and 1-methyl-4-phenylpyridinium
Article | Year |
---|---|
GM1 ganglioside improves dopaminergic markers of rat mesencephalic cultures treated with MPP+.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic-L-Amino-Acid Decarboxylases; Cells, Cultured; Cytarabine; Dopamine; G(M1) Ganglioside; Gestational Age; Immunohistochemistry; Kinetics; Mesencephalon; Neuroglia; Neurons; Neurotoxins; Rats; Rats, Sprague-Dawley; Time Factors; Tyrosine 3-Monooxygenase | 1993 |
Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antimetabolites, Antineoplastic; Astrocytes; Cell Count; Cell Differentiation; Cell Survival; Cells, Cultured; Cytarabine; DNA Replication; Dopamine; Drug Resistance; Mesencephalon; Neurons; Neurotoxins; Osmolar Concentration; Rats; Rats, Wistar | 1997 |